A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

Completed · Phase 3

Conditions studied: Restless Legs Syndrome

In brief

A 12-week clinical research study to evaluate the tolerability, efficacy and safety of ropinirole compared to placebo(an inactive sugar pill) in the treatment of patients with RLS in the United States.

Key facts

Study ID

NCT00225862

Run by

GlaxoSmithKline

People needed

140

Starts

2005-01-01

Expected to finish

2005-12-01

Last updated by the study team

2016-09-15

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Patients with a primary sleep disorder other than RLS.
• Patients with symptoms of secondary RLS (i.e., renal failure, iron deficient anemia, pregnancy) or other movement disorders (i.e., Parkinson's Disease).
• Other inclusion or exclusion criteria to be evaluated by the physician.

Where it is running

• GSK Investigational Site — Alabaster, Alabama, United States
• GSK Investigational Site — Jasper, Alabama, United States
• GSK Investigational Site — Peoria, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Northridge, California, United States
• GSK Investigational Site — Oxnard, California, United States
• GSK Investigational Site — Redondo Beach, California, United States
• GSK Investigational Site — Santa Monica, California, United States
• GSK Investigational Site — Fairfield, Connecticut, United States
• GSK Investigational Site — Largo, Florida, United States
• GSK Investigational Site — Pembroke Pines, Florida, United States
• GSK Investigational Site — St. Petersburg, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Elk Grove Village, Illinois, United States
• GSK Investigational Site — Flossmoor, Illinois, United States
• GSK Investigational Site — Topeka, Kansas, United States
• GSK Investigational Site — Baton Rouge, Louisiana, United States
• GSK Investigational Site — Frederick, Maryland, United States
• GSK Investigational Site — Newton, Massachusetts, United States
• GSK Investigational Site — Newton Center, Massachusetts, United States
• GSK Investigational Site — Bingham Farms, Michigan, United States
• GSK Investigational Site — Edison, New Jersey, United States
• GSK Investigational Site — Albuquerque, New Mexico, United States
• GSK Investigational Site — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.